Restoration of microRNA-18a results in an improvement of Imatinib therapy on secondary imatinib-resistance metastatic melanoma
Imatinib generated remarkable clinical response in melanomas harboring c-kit mutation.However,melanoma resistance to imatinib develops rather quickly in most of the patients.
Yan Kong Long Liang Xiaowei Xu Lu Si Lili Mao Bixia Tang Jie Dai Zhihong Chi Xinan Sheng Chuanliang Cui Siming Li Bin Lian Jun Guo
Department of Renal cancer and Melanoma, Peking University School of Oncology, Beijing Cancer Hospit Department of Pathology and Laboratory Medicine, Abramson Cancer Center of the University of Pennsyl
国内会议
厦门
英文
123-124
2013-09-25(万方平台首次上网日期,不代表论文的发表时间)